Clinical Trial Update: Study of Single Agent Lenalidomide in Older Adults With Newly Diagnosed Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating single-agent lenalidomide in older adults with newly diagnosed multiple myeloma has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2021-02-23